Transient visual decrease after photodynamic therapy. A refractive problem?;Passagere visusminderung nach photodynamischer therapie. Ein refraktives problem?

Ophthalmologe

Volumn 102, Issue 1, 2005, Pages 58-63

  Mennel, S ^a,b   Hausmann, N ^b   Meyer, C H ^a   Horle S ^a   Peter, S ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Landeskrankenhaus Feldkirch   (Austria)

Author keywords

Hyperopic shift; Macular edema; PDT; Photodynamic therapy; Transient visual decrease

Indexed keywords

ARTICLE; BIOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; CORRELATION ANALYSIS; EYE REFRACTION; FEMALE; FOLLOW UP; HUMAN; HYPERMETROPIA; INTERMETHOD COMPARISON; LINEAR SYSTEM; MALE; OPTICAL COHERENCE TOMOGRAPHY; PARAMETER; PHOTODYNAMIC THERAPY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; RETINA; RETINA MACULA EDEMA; THREE DIMENSIONAL IMAGING; ULTRASOUND; VISUAL ACUITY;

EID: 11844251030     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-004-1065-6     Document Type: Article

References (18)

1. Blinder KJ, Blumenkranz MS, Bressler NM et al. (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no. 3. Ophthalmology 110:667-673
2. Costa RA, Farah ME, Cardillo JA et al. (2003) Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 23:159-165
3. Hee MR, Puliafito CA, Duker JS (1998) Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105:360-370
4. Husain D, Miller JW, Michaud N et al. (1996) Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 114:978-985
5. Kramer M, Miller JW, Michaud N et al. (1996) Liposomal benzoporphyrin derivate verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology 103:427-438
6. Massin P, Vicaut E, Haouchine B et al. (2001) Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119:1135-1142
7. Mennel S, Schmidt JC, Meyer CH (2003) Therapeutic strategies in choroidal neovascularizations secondary to angioid streaks. Am J Ophthalmol 136:580-582
8. Mennel S, Meyer CH, Schmidt JC, Rodrigues EB (2004) Dreidimensionale optische Kohärenztomographie zur Verlaufskontrolle von Makulaödemen nach intravitrealer Triamcinolonapplikation. Spektrum Augenheilkd 18:48-54
9. Michels S, Schmidt-Erfurth U (2003) Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 44:2147-2154
10. Muller-Velten R, Michels S, Schmidt-Erfurth U, Laqua H (2003) Photodynamic therapy: extended indication. Ophthalmologe 100:384-390
11. Porrini G, Giovannini A, Amato G et al. (2003) Photodynamic therapy of circumscribed choroidal hemangioma. Ophthalmology 110:674-680
12. Rogers AH, Martidis A, Greenberg PB, Puliafito CA (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566-576
13. Schmidt-Erfurth U, Hasan T, Gragoudas E et al. (1994) Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 101:1953-1961
14. Schmidt-Erfurth U, Laqua H (2001) Photodynamic therapy: Recommendations for indication and treatment. Ophthalmologe 98:216-219
15. Schnurrbusch UEK, Welt K, Horn LC, Wiedemann P, Wolf S (2001) Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol 85:1086-1091
16. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year result of 2 randomized clinical trial - TAP report. Arch Ophthalmol 117:1329-1345
17. Verteporfin in Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year result of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541-560
18. Verteporfin Roundtable 2000 and 2001 Participants; Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators (2002) Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22:6-18